Jun 16, 2020 The U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19…
Recent Post
- Loan Licensing in Pharmaceutical Manufacturing: Key Principles, Guidelines, and Regulatory Framework
- Safe Handling of Narcotic and Psychotropic Drugs in a Wholesale Warehouse: A Complete Guide
- Understanding the Requirements for a Validation Master Plan (VMP) as per Regulatory Agencies: USFDA, EU GMP, MHRA, and PIC/S
- Complete Procedure to Meet CDSCO License Mandate of Class C & D Non-Notified Medical Devices
- Complete list of approved FDC